PAT BROWNE

I'm on a mission to change the way we view aging. I want us to have the tools we need to have the best next chapter.

 

NEXT CHPTR CHATS™ was born in 2022 — out of uncertainty, out of a question.

 

After a successful career in advertising spanning continents, retirement left me staring at a blank page. No roadmap. No clear path forward. Then I started talking to other women, and we were all asking the same thing: What now?

 

What now is everything. It’s the rest of our lives. It may be the last chapter; it may also be the longest. The question isn’t if we’ll age — it’s how. How do we stay happy? Healthy? Fulfilled? How do we reclaim purpose and vitality?

 

SEASON 1 revealed a truth. We struggle to see the future because we’ve never seen it represented. Where are the stories and pictures of women aging with strength, ambition, and joy?

 

SEASON 2 tackled the crisis of women’s health. Menopause isn’t a moment — it’s the rest of our lives. Yet only 6% of federal funding goes to women’s health research, and a mere 20% of that focuses on mature women’s health. Meanwhile, heart disease silently claims more women’s lives than all cancers combined. Twice as many women as men die from heart attacks. Why aren’t we talking about this?

 

SEASON 3 saw us move to YouTube and now...

 

Season 4 is action. NEXT CHPTR CHATS™ is now trademarked and we’re moved to TALK RADIO with a weekly 1-hour show on SAUGA960 AM. Listen to us on Mondays at 3:00 & 7:00 pm and then again on Saturdays at 10:00 pm. You can always hear us through this website or look for us wherever you get your podcasts from.

 

We’re diving deep into Mature Women’s Health — bringing in experts, breaking taboos, and taking back control of our well-being. Through real conversations, knowledge, and laughter, we’re building a future of purpose, passion, and power.

 

We’re just getting started. Aging isn’t a limitation — it’s a superpower. Let’s embrace it, celebrate it, and create a future where we thrive. This is our time. This is our NEXT CHPTR.